Vor Biopharma (VOR) Depreciation and Depletion (2020 - 2026)
Vor Biopharma (VOR) reported Depreciation and Depletion of $28000.0 for Q1 2026, down 96.5% year-over-year from $800000.0 in Q1 2025, and down 22.22% on a QoQ basis from $36000.0 in Q4 2025.
Vor Biopharma (VOR) has 7 years of Depreciation and Depletion data on file, last reported at $28000.0 in Q1 2026.
- Quarterly Depreciation and Depletion fell 96.5% year-over-year to $28000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (down 37.41% YoY) and the FY2025 annual result came in at $2.9 million, down 17.14% from the prior year.
- Depreciation and Depletion slipped to $28000.0 in Q1 2026 per VOR's latest filing, from $36000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $2.1 million in Q2 2025 and bottomed at -$36000.0 in Q3 2025.
- The 5-year median for Depreciation and Depletion is $837000.0 (2023), against an average of $736647.1.
- The widest annual swing landed in 2022, when Depreciation and Depletion surged 200.0%; it then plunged 104.0% in 2025.
- Tracing VOR's Depreciation and Depletion over 5 years: stood at $632000.0 in 2022, then jumped by 42.41% to $900000.0 in 2023, then dropped by 11.11% to $800000.0 in 2024, then sank by 95.5% to $36000.0 in 2025, then declined by 22.22% to $28000.0 in 2026.
- Per Business Quant, the three latest VOR Depreciation and Depletion figures stand at $28000.0 (Q1 2026), $36000.0 (Q4 2025), and -$36000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Vor Biopharma | 628.83 Mn | 628.83 Mn | - | 28,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28,000.00 |
| Mar 31, 2026 | 28,000.00 |
| Dec 31, 2025 | 36,000.00 |
| Dec 31, 2025 | 36,000.00 |
| Sep 30, 2025 | -36,000.00 |
| Sep 30, 2025 | -36,000.00 |
| Jun 30, 2025 | 2.10 Mn |
| Jun 30, 2025 | 2.10 Mn |
| Mar 31, 2025 | 800,000.00 |
| Mar 31, 2025 | 800,000.00 |
| Dec 31, 2024 | 800,000.00 |
| Dec 31, 2024 | 800,000.00 |
| Sep 30, 2024 | 900,000.00 |
| Sep 30, 2024 | 900,000.00 |
| Jun 30, 2024 | 900,000.00 |
| Jun 30, 2024 | 900,000.00 |
| Mar 31, 2024 | 900,000.00 |
| Mar 31, 2024 | 900,000.00 |
| Dec 31, 2023 | 900,000.00 |
| Dec 31, 2023 | 900,000.00 |
| Sep 30, 2023 | 900,000.00 |
| Sep 30, 2023 | 900,000.00 |
| Jun 30, 2023 | 900,000.00 |
| Jun 30, 2023 | 900,000.00 |
| Mar 31, 2023 | 837,000.00 |
| Mar 31, 2023 | 837,000.00 |
| Dec 31, 2022 | 632,000.00 |
| Dec 31, 2022 | 632,000.00 |
| Sep 30, 2022 | 900,000.00 |
| Sep 30, 2022 | 900,000.00 |
| Jun 30, 2022 | 600,000.00 |
| Jun 30, 2022 | 600,000.00 |
| Mar 31, 2022 | 426,000.00 |
| Mar 31, 2022 | 426,000.00 |
| Dec 31, 2021 | 434,000.00 |
| Dec 31, 2021 | 434,000.00 |
| Sep 30, 2021 | 300,000.00 |
| Sep 30, 2021 | 300,000.00 |
| Jun 30, 2021 | 400,000.00 |
| Jun 30, 2021 | 400,000.00 |
| Mar 31, 2021 | 311,000.00 |
| Mar 31, 2021 | 311,000.00 |
| Dec 31, 2020 | 205,000.00 |
| Dec 31, 2020 | 205,000.00 |
| Sep 30, 2020 | 200,000.00 |
| Sep 30, 2020 | 200,000.00 |
| Jun 30, 2020 | 100,000.00 |
| Jun 30, 2020 | 100,000.00 |
| Mar 31, 2020 | 66,000.00 |
| Mar 31, 2020 | 66,000.00 |